发明名称 |
RECOMBINANT HUMAN INTERFERON-LIKE PROTEINS |
摘要 |
<p>This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.</p> |
申请公布号 |
KR20100033468(A) |
申请公布日期 |
2010.03.30 |
申请号 |
KR20097003909 |
申请日期 |
2007.06.22 |
申请人 |
NOVAGEN HOLDING CORPORATION |
发明人 |
WANG HAITAO;MAO CHUNSHENG;LI JIZHI;WANG LING;DU YONG;LIU LONGBIN;XU JING;ZHANG RUI |
分类号 |
C12N15/20;A61K38/21;C07K14/555;C07K19/00 |
主分类号 |
C12N15/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|